Sendas Distribuidora S.A. (ASAIY) Q2 2025 Earnings Call Transcript

Assaí Atacadista (ASAIY) reported Q2 2025 revenue of BRL 21 billion and a pre-IFRS EBITDA margin of 5.7%, a 30 basis point increase year-over-year, attributed to ongoing store maturity and strict expense control. Despite same-store sales remaining below food inflation (7-7.5%) due to a persistent 3.5-4% "trade-down" movement, the company generated BRL 2.7 billion in free cash flow and reduced net debt by BRL 200 million, lowering leverage to 3.17x with a year-end target of 2.6x. Management emphasized strategic initiatives including the successful maturation of converted stores, expansion into private labels, and exploration of new product categories like electronics and potentially pharmaceuticals, leveraging its broad customer base to drive future share of wallet growth.

Analysis

Sendas Distribuidora (Assaí) demonstrated strong operational execution and financial discipline in Q2 2025 despite a challenging consumer environment. The company reported a 30 basis point year-over-year increase in its pre-IFRS EBITDA margin to 5.7% on BRL 21 billion in revenue, a result attributed to maturing stores and strict expense controls. This margin expansion is particularly notable given the primary headwind of same-store sales growth lagging behind the 7-7.5% food inflation rate, driven by a persistent 3.5-4% consumer "trade-down" to cheaper products. Management has successfully prioritized balance sheet health, generating BRL 2.7 billion in free cash flow over the last twelve months, which supported a BRL 200 million reduction in net debt and lowered leverage to 3.17x net debt/EBITDA. The company is on track to meet its year-end leverage target of 2.6x, further bolstered by a successful debt reprofiling that extended average maturity to 39 months and reduced borrowing costs. The strategic conversion of former hypermarkets is yielding positive results, with these stores showing an EBITDA margin improvement from 4.1% to 5.1%. Future growth is predicated on increasing share of wallet through new initiatives, including a major private label launch in H2, expansion into new categories like electronics and potentially pharmaceuticals pending legislation, and financial services for B2B clients, all leveraging a newly expanded customer base across all socioeconomic levels.

Key Decisions for Investors

• Investors should monitor same-store sales performance against food inflation, as closing this gap is a primary management objective and a key indicator of success in overcoming the consumer trade-down trend.
• The progression towards the year-end net debt-to-EBITDA target of 2.6x is a critical metric to track, as achieving this would confirm the company's strong cash generation and significantly de-risk its financial profile.
• The rollout of the private label program in the second half of the year and any legislative progress enabling in-store pharmacies represent key potential catalysts for margin expansion and should be watched closely.
• Given management's commentary on low price elasticity and a competitor's aggressive use of payment terms, it is prudent to observe Assaí's market share stability and any potential pressure on its disciplined margin strategy.